These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

731 related items for PubMed ID: 37849256

  • 1. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
    Liu Y, Wang YX, Sun XJ, Ting X, Wu R, Liu XD, Liu CR.
    Zhonghua Fu Chan Ke Za Zhi; 2023 Oct 25; 58(10):755-765. PubMed ID: 37849256
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of microsatellite instability in endometroid carcinoma with deficient mismatch repair].
    Zhang YH, Wu HW, Wang J, Liang ZY.
    Zhonghua Bing Li Xue Za Zhi; 2021 May 08; 50(5):470-475. PubMed ID: 33915653
    [Abstract] [Full Text] [Related]

  • 3. Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancers.
    Riedinger CJ, Esnakula A, Haight PJ, Suarez AA, Chen W, Gillespie J, Villacres A, Chassen A, Cohn DE, Goodfellow PJ, Cosgrove CM.
    Cancer; 2024 Feb 01; 130(3):385-399. PubMed ID: 37751191
    [Abstract] [Full Text] [Related]

  • 4. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
    Timmerman S, Van Rompuy AS, Van Gorp T, Vanden Bempt I, Brems H, Van Nieuwenhuysen E, Han SN, Neven P, Victoor J, Laenen A, Vergote I.
    Gynecol Oncol; 2020 Apr 01; 157(1):245-251. PubMed ID: 31980219
    [Abstract] [Full Text] [Related]

  • 5. A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer.
    Wang C, Kuang W, Zeng J, Ren Y, Liu Q, Sun H, Feng M, Liang D.
    PeerJ; 2023 Apr 01; 11():e15920. PubMed ID: 37663290
    [Abstract] [Full Text] [Related]

  • 6. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
    Goodfellow PJ, Billingsley CC, Lankes HA, Ali S, Cohn DE, Broaddus RJ, Ramirez N, Pritchard CC, Hampel H, Chassen AS, Simmons LV, Schmidt AP, Gao F, Brinton LA, Backes F, Landrum LM, Geller MA, DiSilvestro PA, Pearl ML, Lele SB, Powell MA, Zaino RJ, Mutch D.
    J Clin Oncol; 2015 Dec 20; 33(36):4301-8. PubMed ID: 26552419
    [Abstract] [Full Text] [Related]

  • 7. Investigation of discrepant mismatch repair immunohistochemistry and microsatellite instability polymerase chain reaction test results for gynecologic cancers using next-generation sequencing.
    Smithgall MC, Remotti H, Hsiao SJ, Mansukhani M, Liu-Jarin X, Fernandes H.
    Hum Pathol; 2022 Jan 20; 119():41-50. PubMed ID: 34666078
    [Abstract] [Full Text] [Related]

  • 8. Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors.
    Salem ME, Bodor JN, Puccini A, Xiu J, Goldberg RM, Grothey A, Korn WM, Shields AF, Worrilow WM, Kim ES, Lenz HJ, Marshall JL, Hall MJ.
    Int J Cancer; 2020 Nov 15; 147(10):2948-2956. PubMed ID: 32449172
    [Abstract] [Full Text] [Related]

  • 9. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
    Ryan NAJ, McMahon R, Tobi S, Snowsill T, Esquibel S, Wallace AJ, Bunstone S, Bowers N, Mosneag IE, Kitson SJ, O'Flynn H, Ramchander NC, Sivalingam VN, Frayling IM, Bolton J, McVey RJ, Evans DG, Crosbie EJ.
    PLoS Med; 2020 Sep 15; 17(9):e1003263. PubMed ID: 32941469
    [Abstract] [Full Text] [Related]

  • 10. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT, Calkins SM, Karnezis AN, Grenert JP, Blanco A, Crawford B, Chen LM.
    Am J Surg Pathol; 2014 Jun 15; 38(6):793-800. PubMed ID: 24503759
    [Abstract] [Full Text] [Related]

  • 11. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
    Chao X, Li L, Wu M, Ma S, Tan X, Zhong S, Bi Y, Lang J.
    Cancer Commun (Lond); 2019 Jul 15; 39(1):42. PubMed ID: 31307542
    [Abstract] [Full Text] [Related]

  • 12. Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation.
    McCarthy AJ, Capo-Chichi JM, Spence T, Grenier S, Stockley T, Kamel-Reid S, Serra S, Sabatini P, Chetty R.
    J Pathol Clin Res; 2019 Apr 15; 5(2):115-129. PubMed ID: 30387329
    [Abstract] [Full Text] [Related]

  • 13. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations.
    Haraldsdottir S, Hampel H, Tomsic J, Frankel WL, Pearlman R, de la Chapelle A, Pritchard CC.
    Gastroenterology; 2014 Dec 15; 147(6):1308-1316.e1. PubMed ID: 25194673
    [Abstract] [Full Text] [Related]

  • 14. Practical guidance for mismatch repair-deficiency testing in endometrial cancer.
    Stelloo E, Jansen AML, Osse EM, Nout RA, Creutzberg CL, Ruano D, Church DN, Morreau H, Smit VTHBM, van Wezel T, Bosse T.
    Ann Oncol; 2017 Jan 01; 28(1):96-102. PubMed ID: 27742654
    [Abstract] [Full Text] [Related]

  • 15. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
    Jin W, Wang LQ, Liu Y, Liu AJ.
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec 25; 53(12):823-830. PubMed ID: 30585020
    [Abstract] [Full Text] [Related]

  • 16. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
    Najdawi F, Crook A, Maidens J, McEvoy C, Fellowes A, Pickett J, Ho M, Nevell D, McIlroy K, Sheen A, Sioson L, Ahadi M, Turchini J, Clarkson A, Hogg R, Valmadre S, Gard G, Dooley SJ, Scott RJ, Fox SB, Field M, Gill AJ.
    Pathology; 2017 Aug 25; 49(5):457-464. PubMed ID: 28669579
    [Abstract] [Full Text] [Related]

  • 17. Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
    Kahn RM, Gordhandas S, Maddy BP, Baltich Nelson B, Askin G, Christos PJ, Caputo TA, Chapman-Davis E, Holcomb K, Frey MK.
    Cancer; 2019 Sep 15; 125(18):3172-3183. PubMed ID: 31150123
    [Abstract] [Full Text] [Related]

  • 18. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation.
    Kaya M, Post CCB, Tops CM, Nielsen M, Crosbie EJ, Leary A, Mileshkin LR, Han K, Bessette P, de Boer SM, Jürgenliemk-Schulz IM, Lutgens L, Jobsen JJ, Haverkort MAD, Nout RA, Kroep J, Creutzberg CL, Smit VTHBM, Horeweg N, van Wezel T, Bosse T.
    Mod Pathol; 2024 Mar 15; 37(3):100423. PubMed ID: 38191122
    [Abstract] [Full Text] [Related]

  • 19. Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤ 70 years.
    Leenen CH, van Lier MG, van Doorn HC, van Leerdam ME, Kooi SG, de Waard J, Hoedemaeker RF, van den Ouweland AM, Hulspas SM, Dubbink HJ, Kuipers EJ, Wagner A, Dinjens WN, Steyerberg EW.
    Gynecol Oncol; 2012 May 15; 125(2):414-20. PubMed ID: 22306203
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM, Sloan EA, Thomas M, Modesitt SC, Stoler MH, Atkins KA, Moskaluk CA.
    Am J Surg Pathol; 2016 Feb 15; 40(2):155-65. PubMed ID: 26523542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.